Oncology Rounds

The latest news and research on cancer care from the Oncology Roundtable.

We asked, you answered: Cancer program leaders' top priorities

by Deirdre Saulet and Ashley Riley September 10, 2018

Every year, we survey cancer program leaders nationwide about their top priorities to help shape our upcoming research agenda. This year, we asked you to rank your top five topics from a list of 19.

Read more »

Immunotherapy: What patients are hearing—and how to guide their expectations

by Deirdre Saulet and Mallory Kirby August 27, 2018

With over two thousand new immunotherapy agents in clinical and pre-clinical development and the expanding adoption of newly approved treatments, such as CAR T-cell therapy, cancer patients are inundated with promises of new "miracle" drugs. While dramatic advancements in our understanding about cancer biology and treatment are touted in the media, research from Cardinal Health suggests that only 40% of oncologists see precision medicine as a game-changer, while 57% of oncologists believe that it's too soon to predict the long-term impact of precision medicine.

Read more »

What cancer programs should know about the 2019 HOPPS proposed rule

by Deirdre Saulet and Kate Wister August 7, 2018

CMS recently dropped its 2019 HOPPS Proposed Rule. Read on to learn more about CMS' plans to expand site neutrality and 340B reimbursement cuts, along with other proposals affecting cancer programs.

Read more »

The CoC clarifies the survivorship care plan standard: What you need to know

Marisa Deline August 6, 2018

In our 2017 Trending Now in Cancer Care survey, cancer program leaders ranked the Commission on Cancer (CoC) Standard 3.3, Survivorship Care Plan, as the most difficult standard to achieve. 80% of respondents told us that meeting this standard is "somewhat challenging" or "very challenging."

CoC surveys of its accredited organizations have identified similar levels of concern since the standard's introduction. In response, the CoC issued clarifications about the standard in April 2016 and an update in December 2017. Here's what you need to know.

Read more »

Your Oncology Rounds summer reading list

by Deirdre Saulet July 30, 2018

It's hard to believe that we're more than halfway through 2018. To help you get up to speed, we've compiled our top 5 blogs for the year so far.

Read more »

Member asks: How many patients receive surgery downstream of screening mammography?

by Deirdre Saulet and Kenna Hawes July 16, 2018

When you're making the case to invest in screening services or planning for a breast center, it's critical to understand what happens downstream of screening mammography. See what we found when we looked at service utilization, including diagnostic mammograms, biopsies, and surgeries, following breast cancer screening.

Read more »

The new 4-letter word: Attribution in the Oncology Care Model—and how CMMI is responding

by Deirdre Saulet and Soleil Shah July 10, 2018

In conversations with Oncology Care Model (OCM) participants, we've heard consistent concerns about patient attribution, leading to it being dubbed the new four-letter word in cancer payment reform. Fortunately, the Center for Medicare and Medicaid Innovation (CMMI) has been responsive to stakeholders' feedback.

Read more »

Ireland's government failed its women. Here are 3 ways to do better.

by Sarah Adam and Deirdre Saulet June 18, 2018

If you have an eye on European health care news, you may have heard about the controversy surrounding cervical cancer screening in Ireland. Since 2008, the Irish public health service—called the Health Service Executive, or HSE—outsourced lab testing for cervical cancer screenings to a Texas-based lab. In recent weeks, the country has learned that the HSE had agreed to lower accuracy testing with the U.S. lab, using manual examination without the use of computer-based imaging that is standard in the United States. As a result, there have been several hundred false negatives and 17 patients have died.

Read more »